Results 191 to 200 of about 85,210 (279)

Inferior‐Lead Lambda (λ) Wave Revealing Critical Right Coronary Artery Stenosis: A Case Report

Annals of Noninvasive Electrocardiology, Volume 31, Issue 2, March 2026.
Lambda (λ) wave pattern observed in the inferior leads (II, III, aVF) associated with critical 95% stenosis of the right coronary artery. Percutaneous coronary intervention with drug‐eluting stent deployment resulted in complete resolution of the λ wave abnormality and long‐term clinical stability from 2020 to 2024.
Jian Xiong, Djandan Tadum Arthur Vithran, Jingjing Chai, Zheng Cao, Zhixiao Wang, Xiaoyong Hu   +5 more
wiley   +1 more source

Differential Causal Associations of Chronic Gastritis and Ulcerative Colitis with Melanoma Risk: A Mendelian Randomization Study Using Large-Sample GWAS Data. [PDF]

Clin Cosmet Investig Dermatol
Jin R, Lu J, Cheng S, Shi S.
europepmc   +1 more source

Review Article: Classic Bismuth Quadruple Therapy for Helicobacter pylori Infection—Questions Focused on Clinical Practice

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 5, Page 616-636, March 2026.
BQT remains the most effective, safe, and practical regimen for H. pylori eradication, ensuring high cure rates across diverse resistance patterns and clinical settings. ABSTRACT Background Classic bismuth quadruple therapy (BQT)—the combination of a proton pump inhibitor, bismuth, tetracycline, and metronidazole—is a standard regimen for treating ...
Javier P. Gisbert, Pablo Parra, Olga P. Nyssen   +2 more
wiley   +1 more source

Post-COVID-19 Effects on Chronic Gastritis and Gastric Cellular and Molecular Characteristics in Male Mice. [PDF]

Cell Mol Gastroenterol Hepatol
Jeong H, Kim SH, Kim J, Jeon D, Uhm C, Oh H, Cho K, Park IH, Oh J, Kim JJ, Jeong SH, Park JH, Park JW, Yun JW, Seo JY, Shin JS, Goldenring JR, Seong JK, Nam KT.   +18 more
europepmc   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, Volume 183, Issue 6, Page 1271-1287, March 2026.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Enhancing Large Language Models With AI Agents for Chronic Gastritis Management: Comprehensive Comparative Study.

JMIR Med Inform
Wang S, Ye Q.
europepmc   +1 more source

Serum metabolic profiling analysis of chronic gastritis and gastric cancer by untargeted metabolomics. [PDF]

Ann Med Surg (Lond)
Afzal H, Shaukat A, Ul Haq MZ, Khaliq N, Zahid M, Shakeel L, Wasay Zuberi MA, Akilimali A.   +7 more
europepmc   +1 more source

The OLGIMA system for gastric cancer risk assessment. A useful method based on the histological Sydney consensus

Histopathology, Volume 88, Issue 4, Page 911-921, March 2026.
The new OLGIMA method for histological gastric cancer risk assessment is based on the severity of glandular atrophy and intestinal metaplasia, in both antrum and corpus, according to the Updated Sydney classification. The highest score of either atrophy or intestinal metaplasia from each location will be used for the final OLGIMA stage.
Pedro Genaro Delgado Guillena, Miriam Cuatrecasas, Sheyla Montori, Nayra Felipez Varela, Joan Llach, Iva Archilla, Pablo Florez‐Diez, Eva Barreiro‐Alonso, Javier Tejedor‐Tejada, Raquel Vicente, M Teresa Soria, Alaín Huerta, Silvia Patricia Ortega, Henar Nuñez, Oliver Patrón, Carolina Mangas, Diana Zaffalon, Luis Hernández, Luis Enrique Yip, Gadea Hontoria, Gonzalo Hijos, Maria Jose Domper‐Arnal, Sara Zarraquiños, Alberto Herreros De Tejada, Alicia Córdoba, Anabella Cuestas, Glòria Fernández‐Esparrach, Leticia Moreira, Eduardo Albéniz, on behalf of EpiGASTRIC/EDGAR Consortium, Joan Llach, Sheyla Montori, Anabella Cuestas, Gloria Fernandez‐Esparrach, Nayra Felipez Varela, Fermín Estremera‐Arevalo, Marta Gómez Alonso, Juan José Vila Costas, Victoria Busto Bea, Juan Carrascosa Gil, Vanesa Jusué Irurita, Alicia Córdoba Iturriagagoitia, Concepción Llanos Chavarri, Irene Amat Villegas, Gregorio Aisa Rivera, Irene Fernández de los Reyes, Gina de Lima Piña, Miguel Ángel Resano, Adriana Yague Hernando, Cristina Caballero Martínez, Alfredo López Cousillas, Miriam Cuatrecasas, Pedro Genaro Delgado Guillena, Javier Tejedor, Elena Arruebo, Silvia Patricia Ortega, Henar Nuñez, Pilar Diez, Diana Zaffalon, Luis Hernández, Gadea Hontoria, Rosa Maria Saíz, Gonzalo Hijos, María Jose Domper, Sara Zarraquiños, Astrid Irene, Alberto Herreros, Diego de Frutos, Fatima Valentin, Jose Santiago, Virginia Piñol, Adelina García, Alicia Martín‐Lagos, Pablo Florez, Eva Barreiro, Adolfo Suarez, Raquel Vicente, M Teresa Soria, Cristina Polo, Carmen Yagüe, Alain Huerta, Oliver Patrón, David Tello, Carolina Mangas, Eva Serrano, Juan Martínez, Rodrigo Jover, Raquel Grajal, Luis Enrique Yip, Patricia Gonçalves, Jenifer Muñoz, Cristina Herrera‐Pariente, Laia Bonjoch, Sergi Castellví‐Bel, Dulce Momblan, Tamara Saurí, Irina Luzko, Elisa Cantú‐Germano, Angels Gines, Ignasi Elizalde, Francesc Balaguer, Angelez Perez‐Aisa, Jennifer Hinojosa, Coral Tejido, Laura Rivas, María Francisco, Manu Puga, Franco Baiocchi, Cristina Alejandra Sánchez, Alba Pereiros, Joaquin Cubiella, Alejandro Ledo, Ma Victoria Alvarez, Marta Garzón, Juan Manuel Martín, Salvador Sobrino, Ana García‐Rodríguez, Ines Gil, Alazne Aguirre, Ainara Maiz, Ines Ariño, María Dolores Pico, Beatriz de Riba, Goretti Hernández, Eduardo Albéniz, Leticia Moreira   +125 more
wiley   +1 more source

Effect of Helicobacter pylori-related chronic gastritis on gastrointestinal microorganisms and brain neurotransmitters in mice. [PDF]

Front Pharmacol
Liu HH, Lin TT, Zhang QJ, Zhang L, Fang JY, Hu L.   +5 more
europepmc   +1 more source

Immune cell infiltration correlates with intestinal permeability, inflammation, and gastrointestinal symptoms in type 1 diabetes

Journal of Diabetes Investigation, Volume 17, Issue 3, Page 420-431, March 2026.
In individuals with type 1 diabetes, immune cell infiltration in the colon mucosa tended to correlate with fecal and systemic markers of intestinal permeability and inflammation, as well as gastrointestinal symptoms. These findings suggest that low‐grade gut immune activation might link the intestinal barrier dysfunction with systemic endotoxin ...
Polina Zalizko, Reinis Isaks, Leonora Pahirko, Aleksejs Fedulovs, Eduards Krustins, Jurijs Nazarovs, Sergejs Dubencovs, Hanne Salmenkari, Markku Lehto, Kaspars Jēkabsons, Una Riekstiņa, Per‐Henrik Groop, Niina Sandholm, Jeļizaveta Sokolovska   +13 more
wiley   +1 more source